In his weekly clinical update, Dr. Griffin discusses the effectiveness of maternal mRNA COVID-19 vaccination during pregnancy against COVID-19–associated hospitalizations in infants aged
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode - Effectiveness of maternal mRNA COVID-19 vaccination during pregnancy against COVID-19–associated hospitalizations in infants (CDC)
- COVID-19 vaccination recommendations and practices for women of reproductive age (CDC)
- Molnupiravir for intra-household prevention of COVID-19 (JOI)
- Delayed peak SARS-CoV-2 viral loads relative to symptom onset and implications for COVID-19 testing programs
- Viral kinetics of sequential SARS-CoV-2 infections (Nature)
- FDA authorizes updated Novavax COVID-19 vaccine (FDA)
- Antiviral efficacy of molnupiravir vs ritonavir/nirmatrelvir in patients with COVID-19 (The Lancet)
- Long-term cardiovascular, cerebrovascular, and other thrombotic complications in COVID-19 survivors (CID)
- SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in coronary vessels (NCR)
- Efficacy of gabapentin For Post–COVID-19
- Contribute to our Floating Doctors fundraiser at PWB
- Letters read on TWiV 1050
- Dr. Griffin’s COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv